Actualizado 18/04/2012 03:02
- Comunicado -

Eisai Opens Representative Office in Dubai (y 2)

        
        - Zonegran(R) (zonisamide) as adjunctive therapy in adult patients with
          partial-onset seizures, with or without secondary generalisation
        - Zebinix(R) (eslicarbazepine acetate) as adjunctive therapy in adult patients
          with partial-onset seizures, with or without secondary generalization
        - Inovelon(R) (rufinamide) for the adjunctive treatment of seizures associated
          with Lennox-Gastaut Syndrome in patients >4 years

CONTACT: For local media information or to attend the Dubai office openingceremony on 18 April 2012, please contact:Khulood Buaisha, Telephone: +971-4-324-5555 / Direct line +971-4-3622713,Email: khulood.buaisha@dhcc.ae; Media Enquiries, Eisai Europe Ltd,Charlotte Andrews / Cressida Robson, +44-(0)7947-231513 /+44-(0)790-831-4155,charlotte_andrews@eisai.net / cressida_robson@eisai.net;Tonic Life Communications, Benjamyn Tan / Leah Peyton, +44-(0)207-798-9262/ +44-(0)7788-191434,benjamyn.tan@toniclc.com / leah.peyton@toniclc.com

Contenido patrocinado